MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...

The development of BRCA-targeted therapies might offer the best opportunities to bring pancreatic ca Use of PCa genetic testing to stratify risk and guide screening and management continues to gain ...

Point of care (POC) testing refers to a laboratory assay that can be performed outside of a centralized facility, with results available to the physician and patient within minutes. One of the most ...

The Endocrine Society and various endorsing organizations recently published recommendations for improving and standardizing testosterone testing. Toward Excellence in Testosterone Testing: A ...